Focus: Lunaphore Technologies is a Swiss-based tissue analytics company specializing in in vitro diagnostics platforms for multi-therapeutic applications. The company operates across five major therapeutic areas including ophthalmology, neurology, immunology, hematology, and gastroenterology.
Profile data last refreshed 26m ago · AI intelligence enriched 2w ago
Hot — 85 jobs added in 30d
Net +34 (85 new, 51 removed). Aggressive expansion phase.
Strong fit for early-career scientists and commercialization professionals seeking diagnostic platform experience in a scaling biotech, but requires comfort with pre-clinical stage risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Lunaphore Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Lunaphore Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo